These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9883483)
1. Pirmenol hydrochloride-induced QT prolongation and T wave inversion on electrocardiogram during treatment for symptomatic atrial fibrillation. Abe H; Numata T; Hanada H; Kohshi K; Nakashima Y J UOEH; 1998 Dec; 20(4):339-43. PubMed ID: 9883483 [TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia. Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711 [TBL] [Abstract][Full Text] [Related]
3. Clinical effects and pharmacokinetics of a single oral dose of pirmenol hydrochloride. Atarashi H; Kuruma A; Ino T; Hirayama Y; Saitoh H; Hayakawa H J Cardiovasc Pharmacol; 1996 Apr; 27(4):556-62. PubMed ID: 8847873 [TBL] [Abstract][Full Text] [Related]
4. Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study. Toivonen LK; Nieminen MS; Manninen V; Frick MH Br Heart J; 1986 Feb; 55(2):176-80. PubMed ID: 3510642 [TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study. Houltz B; Darpö B; Edvardsson N; Blomström P; Brachmann J; Crijns HJ; Jensen SM; Svernhage E; Vallin H; Swedberg K Pacing Clin Electrophysiol; 1998 May; 21(5):1044-57. PubMed ID: 9604236 [TBL] [Abstract][Full Text] [Related]
6. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine. Lin JC; Quasny HA Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570 [TBL] [Abstract][Full Text] [Related]
7. Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy. Kawamura M; Munetsugu Y; Tanno K; Kobayashi Y J Cardiovasc Pharmacol; 2013 Jan; 61(1):77-82. PubMed ID: 23107870 [TBL] [Abstract][Full Text] [Related]
8. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. Shantsila E; Watson T; Lip GY Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322 [TBL] [Abstract][Full Text] [Related]
13. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686 [TBL] [Abstract][Full Text] [Related]
14. Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine. Salerno DM; Fifield J; Farmer C; Hodges M Clin Cardiol; 1991 Jan; 14(1):25-32. PubMed ID: 2019027 [TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy. Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967 [TBL] [Abstract][Full Text] [Related]
16. Amiodarone-induced QT prolongation in a newly transplanted heart associated with recurrent ventricular fibrillation. Schwarz ER; Czer LS; Simsir SA; Kass RM; Trento A Cardiovasc J Afr; 2010; 21(2):109-12. PubMed ID: 20532436 [TBL] [Abstract][Full Text] [Related]
17. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias. Hampton EM; Anderson JL; Lutz JR; Nappi JM Eur J Clin Pharmacol; 1986; 31(1):15-22. PubMed ID: 3780822 [TBL] [Abstract][Full Text] [Related]
18. Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. Toivonen LK; Nieminen MS; Manninen V; Frick H Am J Cardiol; 1987 Jun; 59(16):39H-42H. PubMed ID: 2884862 [TBL] [Abstract][Full Text] [Related]
19. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide. Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418 [TBL] [Abstract][Full Text] [Related]
20. [Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation]. Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G Z Kardiol; 1994; 83 Suppl 5():87-96. PubMed ID: 7846950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]